Skip to main content
. 2021 Sep 23;40(44):6235–6247. doi: 10.1038/s41388-021-02017-8

Fig. 7. ISG15 correlates positively with Akt activation in breast cancers.

Fig. 7

A Correlation analysis of ISG15 and UBE2L6 mRNA expression levels in breast cancer samples. The spearman’s correlation is 0.66, p value < 2.2e-16 B Boxplots showing the correlation between an Akt-activity gene-signature and ISG15 mRNA in in lymph node negative basal breast cancer (n = 68), luminal A (n = 174), and luminal B (n = 41). p values are displayed below each graph. C Boxplots showing the correlation between an Akt-activity gene-signature and ISG15 mRNA in in lymph positive basal breast cancer (n = 36), luminal A (n = 188) and luminal B (n = 53). p values are displayed below each graph. D Correlation between pAkt and ISG15 mRNA levels in tumours without lymph node metastasis as a whole (n = 166) or classified by subtype; luminal A (n = 62), luminal B (n = 17), basal (n = 28) and HER2 (n = 6). E Correlation as in D in tumours positive for lymph node metastasis as a whole (n = 156) or classified by subtype: Luminal A (n = 65), Luminal B (n = 18), Basal (n = 13) and HER2 + (n = 9). F As B for UBE2L6 mRNA expression. In red boxes, tumour subtypes that showed a statistically significant correlation between pAkt and ISG15 or UBE2L6 mRNA.